Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,547 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003162 | Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer | completed | Phase 3 | 949 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 17, 2015 | clinicaltrials |
| NCT00241384 | Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate Cancer | completed | Phase 3 | 396 | Schiffler Cancer CenterOTHER | 1 | Nov 17, 2015 | clinicaltrials |
| NCT00247312 | Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial | completed | Phase 3 | 319 | Schiffler Cancer CenterOTHER | 1 | Nov 17, 2015 | clinicaltrials |
| NCT01234311 | A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer | completed | Phase 3 | 1,245 | Active Biotech ABINDUSTRY | 37 | Oct 21, 2015 | clinicaltrials |
| NCT00685646 | Androgen Blockade Therapy With or Without Zoledronic Acid in Treating Patients With Prostate Cancer and Bone Metastases(ZAPCA) | completed | Phase 3 | 227 | Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanOTHER | 1 | Oct 16, 2015 | clinicaltrials |
| NCT00215631 | Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer? | terminated | Phase 3 | 100 | Erasmus Medical CenterOTHER | 1 | Sep 15, 2015 | clinicaltrials |
| NCT01656161 | Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer | completed | Phase 3 | 120 | Debiopharm International SAINDUSTRY | 1 | Sep 15, 2015 | clinicaltrials |
| NCT01011751 | Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma | completed | Phase 3 | 311 | TakedaINDUSTRY | 1 | Jul 30, 2015 | clinicaltrials |
| NCT01122121 | Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer | completed | Phase 3 | 273 | TakedaINDUSTRY | 1 | Jul 29, 2015 | clinicaltrials |
| NCT01546623 | A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapy | completed | Phase 3 | 160 | TakedaINDUSTRY | 1 | Jul 21, 2015 | clinicaltrials |
| NCT00809458 | Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer | terminated | Phase 3 | 15 | New Mexico Cancer Research AllianceOTHER | 1 | Jul 16, 2015 | clinicaltrials |
| NCT01744366 | One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population(PANDA) | completed | Phase 3 | 285 | Ferring PharmaceuticalsINDUSTRY | 1 | Jun 23, 2015 | clinicaltrials |
| NCT00581113 | Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases | terminated | Phase 3 | 8 | Virginia Commonwealth UniversityOTHER | 1 | Jun 11, 2015 | clinicaltrials |
| NCT01242748 | A Degarelix Trial in Patients With Prostate Cancer | terminated | Phase 3 | 288 | Ferring PharmaceuticalsINDUSTRY | 13 | Jun 3, 2015 | clinicaltrials |
| NCT00215683 | An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer | completed | Phase 2 / Phase 3 | 137 | Ferring PharmaceuticalsINDUSTRY | 7 | Apr 1, 2015 | clinicaltrials |
| NCT02382094 | Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapy | completed | Phase 3 | 110 | Karolinska University HospitalOTHER | 0 | Mar 6, 2015 | clinicaltrials |
| NCT00846976 | Treatment Protocol to Monitor the Safety of a 200 mg Dose of Bicalutamide in Patients With Advanced Prostate Cancer | completed | Phase 3 | 101 | AstraZenecaINDUSTRY | 1 | Jan 21, 2015 | clinicaltrials |
| NCT02258087 | HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.(PROMOBRA) | unknown | Phase 2 / Phase 3 | 50 | National Institute of Oncology, HungaryOTHER | 1 | Oct 7, 2014 | clinicaltrials |
| NCT02257827 | Trial Comparing Intensity Modulated Radiotherapy Versus Conformal Radiotherapy to Treat Prostate Cancer With Hypofractionated Schedule | completed | Phase 3 | 220 | Gustavo Viani ArrudaOTHER | 1 | Oct 6, 2014 | clinicaltrials |
| NCT00801242 | Intermittent Treatment With Degarelix of Patients Suffering From Prostate Cancer | completed | Phase 3 | 220 | Ferring PharmaceuticalsINDUSTRY | 6 | Sep 3, 2014 | clinicaltrials |
| NCT00751790 | Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer | completed | Phase 3 | 120 | Debiopharm International SAINDUSTRY | 1 | Jul 25, 2014 | clinicaltrials |
| NCT00949962 | Post-operative or Early Salvage XRT and ADT for High Risk PCa | terminated | Phase 3 | 87 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 4, 2014 | clinicaltrials |
| NCT00378690 | A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD(ICELAND) | completed | Phase 3 | 706 | Astellas Pharma IncINDUSTRY | 10 | Jun 4, 2014 | clinicaltrials |
| NCT00946920 | A Trial of Degarelix in Patients With Prostate Cancer | completed | Phase 3 | 859 | Ferring PharmaceuticalsINDUSTRY | 14 | Jun 2, 2014 | clinicaltrials |
| NCT00110214 | Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | completed | Phase 3 | 1,050 | National Cancer Institute (NCI)NIH | 1 | May 9, 2014 | clinicaltrials |
| NCT00242567 | Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer | completed | Phase 3 | 522 | Novartis PharmaceuticalsINDUSTRY | 10 | May 7, 2014 | clinicaltrials |
| NCT00638690 | Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy | completed | Phase 3 | 1,195 | Cougar Biotechnology, Inc.INDUSTRY | 12 | Apr 30, 2014 | clinicaltrials |
| NCT00175396 | Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy | unknown | Phase 3 | 400 | University of British ColumbiaOTHER | 1 | Mar 17, 2014 | clinicaltrials |
| NCT00004001 | S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 3 | 770 | SWOG Cancer Research NetworkNETWORK | 1 | Feb 25, 2014 | clinicaltrials |
| NCT00177619 | Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study) | completed | Phase 3 | 120 | University of PittsburghOTHER | 1 | Feb 11, 2014 | clinicaltrials |
| NCT01715064 | Acute Effects of Exercise on the Cortical Silent Period in Prostate Cancer Patients | completed | Phase 2 / Phase 3 | 36 | University of Guelph-HumberOTHER | 1 | Feb 10, 2014 | clinicaltrials |
| NCT00295802 | Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer | unknown | Phase 2 / Phase 3 | 141 | EDAP TMS S.A.INDUSTRY | 2 | Feb 7, 2014 | clinicaltrials |
| NCT00767286 | Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | completed | Phase 3 | — | Radiation Therapy Oncology GroupNETWORK | 0 | Jan 28, 2014 | clinicaltrials |
| NCT00922129 | Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer | withdrawn | Phase 2 / Phase 3 | 0 | St. Joseph's Healthcare HamiltonOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00398281 | Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer | completed | Phase 3 | 450 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00003290 | Radiation Therapy in Treating Patients With Prostate Cancer | completed | Phase 3 | 800 | Medical Research CouncilOTHER_GOV | 2 | Dec 4, 2013 | clinicaltrials |
| NCT00129142 | Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy | completed | Phase 3 | 1,200 | GTxINDUSTRY | 2 | Nov 15, 2013 | clinicaltrials |
| NCT00884273 | Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients | completed | Phase 3 | 182 | Ferring PharmaceuticalsINDUSTRY | 8 | Nov 13, 2013 | clinicaltrials |
| NCT00831233 | Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer | terminated | Phase 3 | 42 | Ferring PharmaceuticalsINDUSTRY | 3 | Nov 11, 2013 | clinicaltrials |
| NCT00002703 | Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer | completed | Phase 3 | 390 | Proton Radiation Oncology GroupOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00005075 | Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer | terminated | Phase 3 | — | EDAP TechnomedINDUSTRY | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00514917 | A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)(Rising PSA) | terminated | Phase 3 | 413 | SanofiINDUSTRY | 9 | Nov 4, 2013 | clinicaltrials |
| NCT00765479 | Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer | completed | Phase 2 / Phase 3 | 284 | University of Illinois at ChicagoOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00363285 | Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer | unknown | Phase 3 | 900 | St. Bartholomew's HospitalOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00376792 | Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer | unknown | Phase 3 | 396 | Scandinavian Prostate Cancer GroupNETWORK | 5 | Aug 26, 2013 | clinicaltrials |
| NCT00796458 | Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer | unknown | Phase 3 | 200 | A.O.U. San Giovanni Battista di Torino, ItalyOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00110162 | Androgen Deprivation Therapy in Treating Patients With Prostate Cancer | unknown | Phase 3 | 2,000 | Peter MacCallum Cancer Centre, AustraliaOTHER | 2 | Aug 7, 2013 | clinicaltrials |
| NCT00632138 | Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate | completed | Phase 3 | 800 | Aberdeen Royal InfirmaryOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT01901042 | Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis Symptoms | completed | Phase 2 / Phase 3 | 20 | Federal University of Mato GrossoOTHER | 0 | Jul 17, 2013 | clinicaltrials |
| NCT00003367 | Diet and PSA Levels in Patients With Prostate Cancer | completed | Phase 3 | 154 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Nov 17, 2015source: clinicaltrials